Clin2
NCT07793513Possibly a fitNot yet recruiting

Study of an investigational vaccine in healthy infants

PertussisDiphtheriaTetanusPoliomyelitisHepatitis BHaemophilus Influenzae Type b

Part of Brain & nervous system, Digestive system, Infections, Lungs & breathing clinical trials.

This study tests an experimental vaccine (BK1803) to see if it is safe and effective in healthy infants aged 2 to 6 months. It may help protect against several serious diseases.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
344 people
Ages
2 months to 6 months
Study type
Interventional

Who can take part

  • Your baby is between 2 and 6 months old.
  • Your baby is healthy and was not born significantly premature or with low birth weight.
  • Your baby has not had these infections or vaccines before: Hib, pertussis, diphtheria, tetanus, polio, hepatitis B.
  • Your baby has no immune system problems or close relatives with congenital immune deficiency.
  • Your baby is not taking medications that weaken the immune system or has blood clotting issues.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06947499Recruiting· Phase 2/Phase 3
Testing a 6-in-1 infant vaccine in healthy babies

This study tests a new vaccine that protects babies against 6 diseases (diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib) in just one shot. It’s for healthy infants starting at 6–8 weeks old as their first series of vaccinations.

Dasmariñas, Cavite
NCT06618196Not yet recruiting· Phase 2
Testing a new vaccine for infants at 2, 4, and 6 months

This trial tests a new vaccine (LR20062) to see how well it protects healthy babies against several diseases. Your baby would receive the vaccine at their 2-month, 4-month, and 6-month checkups.

NCT06605755Recruiting
Testing a pentavalent vaccine in 2-month-old babies

This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.

Nanjing, Jiangsu
NCT07418372Not yet recruiting· Phase 1/Phase 2
Testing a reduced-dose diphtheria-tetanus-pertussis vaccine

This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.

Chongqing, Chongqing Municipality
NCT06690515Not yet recruiting· Phase 1/Phase 2
Infant vaccine safety and immune response study

This study tests a combined vaccine for six diseases in infants 6-11 weeks old. It aims to check if the vaccine is safe and helps babies build protection against diphtheria, tetanus, whooping cough, hepatitis B, Hib, and polio.

Bandung, West Java
NCT06344065Recruiting· Phase 3
New whooping cough combo vaccine for 3-month-old infants

This trial tests a new combination vaccine that protects infants against diphtheria, tetanus, and whooping cough. It is for healthy 3-month-old babies whose parents have not yet given them a similar shot.

Nanning, Guangxi

Hear when a new Pertussis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.